drug-eluting contact lens development

Freya Ophthalmics Inc is developing an innovative drug-eluting contact lens platform to treat eye diseases through targeted, tailored, and sustained drug delivery. Its lead product, MoxiLens™, is described as the first antibiotic bandage contact lens, intended to eliminate eye drop compliance and instillation issues. The company targets therapeutic areas including infection, glaucoma, ocular cystinosis, corneal ulcers, post ocular surgery, and myopia control.

Read more

sustained ocular drug delivery